Proactive Investors - Run By Investors For Investors

CannaRoyalty acquires vape store 180 Smoke in deal valued at C$40M

CannaRoyalty said it purchase 180 Smoke for C$25 million, and an additional C$15 million when it completes certain targets by Dec. 31, 2020
vape store
180 Smoke's revenue grew more than 50% in the eight months to August from a year ago to C$6.78 million.

Ottawa-based firm CannaRoyalty Corp (CSE:CRZ) (OTCMKTS:CNNRF) announced Thursday it will acquire vape chain store 180 Smoke in a deal valued at C$40 million, according to the company. 

CannaRoyalty said it purchase 180 Smoke for C$25 million, and an additional C$15 million upon completion of certain milestones by Dec. 31, 2020.

“As a management team, we are drawn to business models that can be rapidly and profitably scaled with the addition of each new customer, brand and dollar of capital, and 180 Smoke fits this formula. The 180 Smoke management team has built a growing, profitable retail and online vape business along with several strong in-house brands in a fragmented, competitive and highly regulated marketplace,” said Afzal Hasan, president of CannaRoyalty, in a release.

READ: CannaRoyalty’s focus beyond Canada is more than just California Dreamin’

“We expect to be in a position to rapidly leverage 180 Smoke’s existing platform and additional cannabis locations to drive sustainable, accretive growth in the Canadian market,” he added.

180 Smoke currently has 15 locations in Toronto that sell vape and nicotine-related products.

"This deal will give 180 Smoke access through CannaRoyalty to the additional capital and expertise both to execute on those plans as well as to become a force in cannabis retail and brands, together," said Ashutosh Jha, president of 180 Smoke. 

180 Smoke's revenue grew more than 50% in the eight months to August from a year ago to C$6.78 million. 

The acquisition of 180 Smoke comes on the heels of recently-introduced legislation by Ontario in regards to the regulation of private cannabis retail model, which is expected to be rolled out in April. 

Shares of CannaRoyalty were down 1.4% at C$7.14 in Toronto and down 0.5% at US$5.54 in New York. 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full CRZ profile View Profile

CannaRoyalty Corp Timeline

Related Articles

Oncoprex
October 17 2018
The biotech was founded by an investment group led by scientists and driven by a no-nonsense CEO whose stake is more than just business as usual
child
February 08 2019
“If successful, this platform [AP103] has potential in other genetic skin conditions and beyond”
A double helix and a medical person
March 06 2019
Leronlimab, according to the company, is an antiviral agent candidate with fewer side effects, lower toxicity and less frequent doses than daily HIV therapies now in use
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use